Lenvatinib Suppresses Protein Kinase B Signaling and Induces Apoptosis in Osteosarcoma Cells

被引:0
作者
Li, Chun-Yi [1 ]
Chen, Hsin-Chuan [1 ,2 ]
Liao, Chih-Ying [3 ]
Hsu, Fei-Ting [4 ]
Hung, Kuang-Chen [5 ,6 ,7 ,8 ,9 ]
Liu, Kuo-Ching [1 ,10 ]
Chen, Jaw-Chyun [1 ,11 ]
Ku, Ming-Chou [1 ,2 ,12 ,13 ]
机构
[1] Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan
[2] Chung Shan Med Univ, Inst Stomatol, Taichung, Taiwan
[3] Chang Bing Show Chwan Mem Hosp, Dept Radiat Oncol, Changhua, Taiwan
[4] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan
[5] Zuoying Armed Forces Gen Hosp, Dept Surg, Kaohsiung, Taiwan
[6] Natl Def Med Ctr, Dept Surg, Taipei, Taiwan
[7] Taichung Armed Forces Gen Hosp, Dept Surg, Taichung, Taiwan
[8] Cent Taiwan Univ Sci & Technol, Taichung, Taiwan
[9] Natl Chin Yi Univ Technol, Taichung, Taiwan
[10] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan
[11] Da Yeh Univ, Dept Med Bot & Foods Hlth Applicat, Changhua, Taiwan
[12] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan
[13] Show Chwan Mem Hosp, Dept Neurosurg, 542 Sec 1,Chung Shang Rd, Changhua 505, Taiwan
关键词
Lenvatinib; osteosarcoma; AKT; apoptosis; invasion; CYCLIN D1; SORAFENIB; INHIBITION; ACTIVATION; EXPRESSION; PATHWAYS; GROWTH; MMP-9;
D O I
10.21873/anticanres.16790
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Lenvatinib, an oral multikinase inhibitor, has demonstrated promising activity in patients with osteosarcoma (OS). Therefore, it is worth exploring the inhibitory efficacy and mechanism of action of lenvatinib in osteosarcoma. The primary goal of this study was to examine the inhibitory effectiveness and mechanism of lenvatinib on the growth and invasion of OS cells. Materials and Methods: The effects of lenvatinib on cell viability, apoptosis, protein involved in tumor progression, and invasion capability were assessed using MTT assay, flow cytometry, western blotting, and invasion/migration assay on U-2 OS and MG63 cells. apoptosis, as well as extrinsic and intrinsic apoptotic signaling in OS cells. Lenvatinib also significantly decreased the invasion/migration capability, AKT activation, and
引用
收藏
页码:85 / 92
页数:8
相关论文
共 35 条
  • [1] Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC
    Abbas, Ruqaia
    Larisch, Sarit
    [J]. CELLS, 2020, 9 (03)
  • [2] Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas
    Albarran, Victor
    Luisa Villamayor, Maria
    Chamorro, Jesus
    Isabel Rosero, Diana
    Pozas, Javier
    San Roman, Maria
    Carlos Calvo, Juan
    Perez de Aguado, Patricia
    Moreno, Jaime
    Guerrero, Patricia
    Gonzalez, Carlos
    Garcia de Quevedo, Coral
    Alvarez-Ballesteros, Pablo
    Angeles Vaz, Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [3] Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
    Balermpas, P.
    Michel, Y.
    Wagenblast, J.
    Seitz, O.
    Weiss, C.
    Roedel, F.
    Roedel, C.
    Fokas, E.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (02) : 501 - 509
  • [4] HtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAP
    Bao, Wanyuan
    Zhu, Feng
    Duan, Yunfei
    Yang, Yue
    Cai, Huihua
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2015, 70 : 97 - 102
  • [5] Prognostic factor studies in oncology: Osteosarcoma as a clinical example
    Bentzen, SM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 49 (02): : 513 - 518
  • [6] Tricetin inhibits human osteosarcoma cells metastasis by transcriptionally repressing MMP-9 via p38 and Akt pathways
    Chang, Pin-Yu
    Hsieh, Ming-Ju
    Hsieh, Yih-Shou
    Chen, Pei-Ni
    Yang, Jia-Sin
    Lo, Fang-Cheng
    Yang, Shun-Fa
    Lu, Ko-Hsiu
    [J]. ENVIRONMENTAL TOXICOLOGY, 2017, 32 (08) : 2032 - 2040
  • [7] Chen JH, 2015, ANTICANCER RES, V35, P6685
  • [8] Chiang IT, 2012, IN VIVO, V26, P671
  • [9] Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells
    Chiang, I-Tsang
    Chen, Wei-Ting
    Tseng, Chih-Wei
    Chen, Yen-Chung
    Kuo, Yu-Cheng
    Chen, Bi-Jhih
    Weng, Mao-Chi
    Lin, Hwai-Jeng
    Wang, Wei-Shu
    [J]. ANTICANCER RESEARCH, 2017, 37 (01) : 161 - 167
  • [10] ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells
    Contessa, Joseph N.
    Abell, Angela
    Valerie, Kristoffer
    Lin, Peck-Sun
    Schmidt-Ullrich, Rupert K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 851 - 858